Could eye drops replace needles for diabetic eye swelling?

NCT ID NCT06599684

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small Phase 2 study tested INV-102 eye drops in 19 people with diabetic macular edema, a swelling in the back of the eye caused by diabetes. Participants used the drops daily for 8 to 12 weeks. The goal was to see if the drops could improve retinal health and reduce swelling. This is an early step toward a potential non-invasive treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

INV-102 ophthalmic solution (eye drops)

What this could lead to

If successful, this could lead to a simple eye drop treatment for diabetic macular edema, reducing the need for injections.

What could go wrong

This is a small, early-phase pilot study with only 19 participants. It may not show clear benefit, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

background diabetic retinopathy diabetic macular edema diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MedTrials, Inc.

    Dallas, Texas, 75204, United States